Status:

NOT_YET_RECRUITING

Efficacy of the Vacucis Candida® Autovaccine

Lead Sponsor:

University of Santiago de Compostela

Conditions:

Oral Candidiasis

Oral Candidiasis Recurrent

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Introduction: Oral candidiasis is an infectious disease caused by the growth of Candida colonies and their penetration into oral tissues when physical barriers and host defenses are weakened. It const...

Detailed Description

The design of a randomized, randomized (test and placebo) triple-blind (patient, investigator and evaluator) clinical trial is proposed. The clinical trial will be carried out in accordance with the c...

Eligibility Criteria

Inclusion

  • Patients with a history of RT in the head and neck region that directly or indirectly involves any of the jaws.
  • Adult patients
  • Hemodynamically stable patients without contraindications to receive an autovaccine (see exclusion)
  • Patients with a stable oncological situation without active tumor
  • Patients who present candidiasis demonstrated by clinical examination (signs and symptoms of candidiasis) and microbiological (culture).

Exclusion

  • Minor patients
  • Pregnant patients
  • Patients with an unstable medical situation, both from a hemodynamic and oncological point of view (advanced tumors with metastases, recurrences or inoperable tumors)
  • Patients undergoing treatment with CT that involves an affectation of the immune system
  • Patient under treatment with antifungals for mycoses of any origin
  • Allergy to the active substance or to any of the other components of Vacucis.
  • Serious disorders of the immune system.
  • Diseases that severely affect immunity.
  • Presence of fever.
  • People with allergies to yeasts
  • People with allergy to chloramphenicol
  • Patients treated with MAOIs (monoamine oxidase inhibitors)

Key Trial Info

Start Date :

April 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT05289375

Start Date

April 30 2025

End Date

December 31 2027

Last Update

October 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad de Santiago de Compostela

Santiago de Compostela, A Coruña, Spain, 15785